Department of Pediatric Cardiology, Amsterdam University Medical Centers, Amsterdam, Netherlands.
Translational Research in Immunology and Inflammation, University of Antwerp, Antwerp, Belgium.
Am J Med Genet A. 2021 Aug;185(8):2464-2470. doi: 10.1002/ajmg.a.62231. Epub 2021 May 5.
Pathogenic heterozygous NEXN variants are associated with progressive dilated cardiomyopathy (DCM) usually presenting around 50 years of age. We describe an asymptomatic boy who had transient DCM at 3 months of age, that resolved by 4 months. Presently, at 11 years of age, he has normal cardiac function with signs of mild DCM on cardiac MRI. Genetic diagnostics revealed a paternally derived, heterozygous 1949_1951del class 4 variant in NEXN. His father had mild DCM with mildly reduced systolic function. The second patient presented with fetal hydrops at 33 weeks gestation requiring emergency caesarian delivery. Postnatally she required ventilation and continuous inotropic support for left ventricle systolic dysfunction. She died after 2 weeks when therapy was withdrawn. Homozygous c.1174C > T,p.(R392*) class 4 variants in the NEXN gene were found via WES. Microscopic investigation showed endomyocardial fibroelastosis. Her parents, both heterozygous carriers, had normal cardiac function and the family history was normal. These patients show a new clinical spectrum of pediatric cardiac disease seen in heterozygous and homozygous NEXN variants, ranging from mild, transient DCM to a severe, fatal neonatal DCM. These patients support the inclusion of the NEXN gene in the investigation of pediatric patients with DCM, even in cases with transient DCM.
致病性杂合性 NEXN 变体与进行性扩张型心肌病(DCM)相关,通常在 50 岁左右发病。我们描述了一位无症状男孩,他在 3 个月大时曾短暂患有 DCM,4 个月时得到缓解。目前,他 11 岁,心脏功能正常,但心脏 MRI 显示有轻度 DCM 的迹象。基因诊断显示,他从父亲那里遗传了杂合性的 NEXN 1949_1951del 类 4 变异体。他的父亲患有轻度 DCM,伴有收缩功能轻度降低。第二位患者在 33 周妊娠时出现胎儿水肿,需要紧急剖腹产。出生后,她因左心室收缩功能障碍需要通气和持续正性肌力支持。在停止治疗 2 周后,她死亡。通过 WES 发现第二位患者携带 NEXN 基因的纯合性 c.1174C>T,p.(R392*)类 4 变异体。显微镜检查显示心内膜心肌纤维弹性组织增生症。她的父母均为杂合子携带者,心脏功能正常,家族史正常。这些患者表现出杂合子和纯合子 NEXN 变异体导致的儿科心脏病的新临床谱,从轻度、短暂性 DCM 到严重、致命的新生儿 DCM 不等。这些患者支持将 NEXN 基因纳入对患有 DCM 的儿科患者的调查中,即使是在短暂性 DCM 病例中。